2013 Fiscal Year Final Research Report
Development of anti-diabetic zinc medicine protecting the pancreatic B cells through the GPR39-stimulating Pdx-1 expression
Project/Area Number |
23590653
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Applied pharmacology
|
Research Institution | Kyoto Pharmaceutical University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
YOSHIKAWA Yutaka 神戸女子大学, 健康福祉学部, 教授 (20388028)
|
Project Period (FY) |
2011 – 2013
|
Keywords | 膵β細胞保護作用 / GPR39 / Pdx-1 / 亜鉛医薬品 / インスリン |
Research Abstract |
Zinc is one of the essential trace elements playing an important role in our life. From the recent studies of molecular biology, the zinc-homeostasis in the animal body has been found to be properly controlled by 22 kinds of zinc transporters. Concerning the Japanese aging of the population, lifestyle-related diseases as metabolic-syndromes mainly derived from obesity and type-2 diabetes are more urgent issues. From these backgrounds, we have investigated the anti-diabetic action and effects of zinc closely related with insulin homeostasis and activity, and succeeded the development of several orally-active zinc complexes. In this study, first we focused to cure both the type 1 and type 2 diabetes on the basis of activatiing transpciption factor, Pdx-1, expressed in the pancreas. Secondly, we indicated the new positive results for both the biochemical and morphological analyses of dramatically improved pancreas and liver in zinc complex-treated type-2 diabetic KK-Ay mice.
|
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] 疾患メタロミクスと酸化ストレス2012
Author(s)
安井裕之, 伊賀瑞紗, 松尾岳志, 吉川豊, 中村任, 久米学, 江原正明, 福田浩之, 平岡勇二
Organizer
第65回日本酸化ストレス学会学術集会
Place of Presentation
徳島(シンポジウム講演)
Year and Date
20120600
-
-
-
-
[Book] 序章,第1, 2, 3, 5, 6, 7, 8, 9, 10章.医薬品分析化学2013
Author(s)
安井裕之(黒田幸弘, 安井裕之, 吉川豊共著)
Total Pages
427
Publisher
京都廣川書店